yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q56506566-FD9A43D8-3DD0-48EF-98E0-3055B0A0524F
Q56506566-FD9A43D8-3DD0-48EF-98E0-3055B0A0524F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q56506566-FD9A43D8-3DD0-48EF-98E0-3055B0A0524F
Reply
P2860
Q56506566-FD9A43D8-3DD0-48EF-98E0-3055B0A0524F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q56506566-FD9A43D8-3DD0-48EF-98E0-3055B0A0524F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc172cd6b2761b1fb79b584cedfb7502d7beabe9
P2860
Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.